We supply Raxibacumab API and biological drug substance to biopharmaceutical companies, pharmaceutical research organizations, contract research organizations, analytical laboratories, formulation development companies, and authorized international buyers.
Our Raxibacumab API supply services support:
Raxibacumab API is supplied with quality parameters evaluated according to applicable biological specifications, validated analytical methods, and customer requirements.
Typical Quality Parameters Include:
Appearance: As per approved specification
Identification: Complies with specification
Protein Identity: As per validated analytical method
Protein Concentration: As per specification
Biological Activity: As per approved specification
Potency: As per validated biological assay
Protein Purity: As per validated analytical method
Monomer Content: As per specification
High Molecular Weight Species: Within specified limits
Aggregates: Within specified limits
Charge Variants: As per specification
Related Proteins: Within specified limits
pH: As per approved specification
Residual Host Cell Proteins: Within specified limits, as applicable
Residual Host Cell DNA: Within specified limits, as applicable
Process-Related Impurities: Within specified limits
Bioburden: Within specified limits
Bacterial Endotoxins: Within specified limits
Sterility: As applicable
Actual specifications may vary depending on product form, manufacturing process, intended use, biological activity requirements, analytical methods, regulatory requirements, and customer-approved specifications.
Raxibacumab API is used in the biopharmaceutical sector as a monoclonal antibody biological drug substance and anthrax toxin-neutralizing antibody.
Raxibacumab binds to the protective antigen component of Bacillus anthracis toxin and inhibits the interaction of protective antigen with host cell receptors. It does not have direct antibacterial activity.
Raxibacumab is associated with authorized biological products used for the treatment of inhalational anthrax in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are unavailable or inappropriate.
The biological drug substance is intended for use by licensed biopharmaceutical manufacturers, pharmaceutical research organizations, contract research organizations, analytical laboratories, and authorized institutions.
Swapnroop Drugs & Pharmaceuticals offers reliable Raxibacumab API sourcing and supply solutions for domestic and international biopharmaceutical requirements.
Our Key Advantages:
We support the export of Raxibacumab API and biological drug substance from India to biopharmaceutical companies, research organizations, analytical laboratories, distributors, and authorized international buyers.
Export documentation, product information, storage requirements, and logistics coordination can be provided based on destination-country requirements, customer specifications, intended use, and applicable regulatory procedures.
We serve pharmaceutical and biopharmaceutical buyers across Asia, Africa, the Middle East, Latin America, and other international markets.
Looking for a reliable Raxibacumab API manufacturer in India, Raxibacumab API supplier in India, Raxibacumab biological drug substance supplier, or monoclonal antibody API exporter from India?
Contact Swapnroop Drugs & Pharmaceuticals for Raxibacumab API requirements, technical documentation, COA, SDS, pricing, packaging details, storage requirements, and export inquiries.
Company: Swapnroop Drugs & Pharmaceuticals
Product: Raxibacumab API
CAS Number: 565451-13-0
Supply Type: Biological API / Monoclonal Antibody Drug Substance / Recombinant Protein
Country of Origin: India
Email: enquiry@sdp.org.in